BSECompany Update2d ago · 27 Oct 2026, 08:53 pm

Intimation of the Audio recording of the earnings call pertaining to the unaudited financial results for the quarter and half year ended September 30, 2026

Onesource Specialty Pharma Ltd · 544292

✦ AI SummaryResults

Onesource Specialty Pharma Ltd has made available the audio recording of its earnings call for the quarter ended September 30, 2026, on its website.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Attachments (1)

📄

4d75f501-b484-4390-9481-96f6ed252a1d.pdf

pdf

Download →
View document text
Corporate Office: Registered Office: Star 1, Opp IIM Bangalore, Bilekahalli, Cyber One, Unit No. 902, Sector 30A, Bannergha(cid:425)a Road, Bengaluru – Plot No - 4 & 6, Vashi, 560076, India Navi Mumbai - 400703, India T: +91 80 6784 0738 T: +91 22 2789 2924 Date: October 27, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G, Dalal Street, Mumbai- 400001 Bandra Kurla Complex, Bandra (E), Mumbai – 400 051 Scrip Code: 544292 Symbol: ONESOURCE Dear Sir/ Madam, Subject: Intimation of Audio Recording of Earnings Call pertaining to the Unaudited Financial Results for the quarter ended September 30, 2026 Pursuant to Regulation 46 & 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the audio recording of Earnings Call held today i.e., October 27, 2026 at 18:30 hrs (IST) for discussing unaudited financial results of the Company for the quarter ended September 30, 2026, has been made available on our Company’s website at: https://www.onesourcecdmo.com/wp-content/uploads/2026/10/Earning_Call_Audio_Recording_for_Q2_FY27.mp3 You are requested to kindly take the same on record. For and on behalf of OneSource Specialty Pharma Limited Trisha A Company Secretary and Compliance Officer Membership Number: A47635 OneSource Specialty Pharma Limited info@onesourcecdmo.com | www.onesourcecdmo.com CIN: L74140MH2007PLC432497